hsa-miR-504

ncRNA information

ncRNA name

hsa-miR-504

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

NRF1

Cancer information

Cancer name

Nasopharyngeal Carcinoma

Cancer site

Nasopharynx

Treatment information

Treatment type

Radiotherapy

Impact of wild-type ncRNA on radiotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-504 might become a promising biomarker of NPC radio-resistance and targeting miR-504 might improve tumor radiation response.

Tissue resource

serum samples from nasopharyngeal carcinoma patients

nasopharyngeal carcinoma radio-resistant cell lines CNE2-IR

nasopharyngeal carcinoma radio-resistant cell lines HK1-IR

nasopharyngeal carcinoma cell lines CNE2

nasopharyngeal carcinoma cell lines HK1

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Xiangya Hospital, Central South University

Country

China

Continent

Asia